Salvatore Alesci
Corporate Officer/Principal chez TAKEDA PHARMACEUTICAL COMPANY LIMITED
Profil
Salvatore Alesci currently works at Takeda Pharmaceutical Co., Ltd., as Head-R & D Global Science & Biomedical Policy and Invea Therapeutics, Inc., as Chief Scientific Officer from 2022.
Postes actifs de Salvatore Alesci
| Sociétés | Poste | Début |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Health Technology |
